Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Dong,Liu

第一单位： State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

作者： Dong,Liu ^[1] ; Fei,Tang ^[1] ; Li,Zhang ^[1] ; Feng,Wan ^[2] ; Li-Yue,Xu ^[1] ; Jing-Nan,Zhang ^[1] ; Xiao-Lan,Zhao ^[1] ; Hui,Ao ^[3] ; Cheng,Peng ^[1]

作者单位： State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China. ^[1] Chengdu No. 1 Pharmaceutical Co. Ltd., Pengzhou, Sichuan, China. ^[2] State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.;Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. ^[3]

关键词 acute kidney injury anisodamine (654-1/654-2)apoptosis inflammatory septic shock

DOI 10.3389/fphar.2024.1421551

PMID 39399464

发布时间 2024-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in pharmacology

2024年15卷

1421551页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除